Using diverse techniques like ELISA, immunohistochemistry, and biodatabase analysis, we found that S100A8 and S100A9 expression levels were significantly elevated in colorectal cancer patient tumor tissues compared to normal tissues. Here, S100A9 is linked to colorectal cancer.